Cargando…
MicroRNA as New Tools for Prostate Cancer Risk Assessment and Therapeutic Intervention: Results from Clinical Data Set and Patients' Samples
Prostate cancer (PCa) is one of the leading causes of cancer-related death in men. Despite considerable advances in prostate cancer early detection and clinical management, validation of new biomarkers able to predict the natural history of tumor progression is still necessary in order to reduce ove...
Autores principales: | Cannistraci, Alessio, Di Pace, Anna Laura, De Maria, Ruggero, Bonci, Désirée |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182080/ https://www.ncbi.nlm.nih.gov/pubmed/25309903 http://dx.doi.org/10.1155/2014/146170 |
Ejemplares similares
-
A microRNA code for prostate cancer metastasis
por: Bonci, D, et al.
Publicado: (2016) -
A predictive signature for therapy assignment and risk assessment in prostate cancer
por: Bonci, Désirée, et al.
Publicado: (2015) -
MicroRNA: an Emerging Therapeutic Target and Intervention Tool
por: Liu, Zhen, et al.
Publicado: (2008) -
The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation
por: Alfonsi, Romina, et al.
Publicado: (2018) -
Five microRNAs in serum as potential biomarkers for prostate cancer risk assessment and therapeutic intervention
por: Guo, Xiaogang, et al.
Publicado: (2018)